International Clinical Research

Name

International Clinical Research

Website

https://icresearch.net

Company type

Private

Founded year

2009

Operating status

Operating

Headcount range

11–50 employees

Short description

International Clinical Research is a private US clinical research site founded in 2009 in Sanford, conducting Phase I-IV trials across therapeutic areas for pharmaceutical and biotech sponsors; its public web presence is currently inactive.

Ownership category

akta.pro rank

Product category

Clinical Research Services

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (54171), Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Health Services (8000)

akta.pro industry

PRIMARYHLAGACAE

Clinical Trial Site Operations & Study Coordination

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Clinical Trial Services & Site Management (SMO)

SECONDARYHLAGACAC

Clinical Site Start-Up & Activation (Regulatory/Ethics/Contracts)

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Clinical Trial Services & Site Management (SMO)

Keywords

• Clinical research services
• Clinical trial site
• Phase I-IV trials
• Therapeutic area research
• Clinical study conduct

Headquarters

HQ city

Sanford

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Infrastructure

Core offering

International Clinical Research is a clinical research site company that conducts Phase I-IV clinical research studies across therapeutic areas. The organization functions as a site-level partner for clinical study execution, accepting studies from sponsors and CROs and operating them through its Sanford, United States-based facility staffed by 11-50 personnel.

Differentiator

Problem solved

Functional benefit

Products and services

• Phase I-IV Clinical Research Studies Execution of Phase I, Phase II, Phase III, and Phase IV clinical research studies across therapeutic areas at a U.S.-based clinical research site in Sanford, serving pharmaceutical sponsors, biotechnology companies, and CROs needing site-level clinical trial conduct.

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Direct peers

• Benchmark Research: Benchmark Research operates multiple clinical trial sites in the US conducting Phase I-IV trials for pharma and CRO sponsors. It is comparable to International Clinical Research as a similarly-sized multi-site SMO with Phase I-IV scope.
• Flourish Research: Flourish Research is a multi-site clinical research organization running Phase II-IV trials in indications including cardiology, endocrinology, and vaccines. It is a direct comparable as a smaller, focused Phase I-IV site network competing for the same sponsor relationships.
• Velocity Clinical Research: Velocity Clinical Research is one of the largest integrated clinical research site networks in the US, conducting Phase I-IV trials across multiple therapeutic areas. It is the most directly comparable scaled SMO to International Clinical Research's described model.
• Clinipace Worldwide: Clinipace is a mid-sized CRO providing Phase II-IV clinical trial services across multiple therapeutic areas for emerging and mid-market biopharma. It is a direct comparable to International Clinical Research in scale and Phase coverage.
• DM Clinical Research: DM Clinical Research operates a multi-site clinical trial network running Phase I-IV trials across therapeutic areas for pharmaceutical and biotech sponsors. It is a direct comparable to International Clinical Research as a multi-therapeutic, multi-phase site operator.
• Worldwide Clinical Trials: Worldwide Clinical Trials is a mid-sized CRO focused on Phase I-IV clinical trial execution across multiple therapeutic areas. It is a direct comparable mid-sized peer with similar Phase I-IV and multi-TA positioning to International Clinical Research.

Broad incumbents

• Syneos Health: Syneos Health is a global clinical and commercial solutions provider with Phase I-IV CRO and site management capabilities. It is a broad incumbent peer with overlapping Phase I-IV clinical trial execution across therapeutic areas.
• IQVIA: IQVIA is the world's largest CRO with both Phase I-IV trial execution and an extensive site network. It is a broad incumbent peer that competes for sponsor mandates and influences site selection across the same Phase I-IV therapeutic landscape.
• Medpace: Medpace is a mid-sized full-service CRO with established site relationships and Phase I-IV capabilities. It represents the scaled incumbent that International Clinical Research would interface with either as a sponsor-delegated partner or as a competitor for study placement.
• ICON plc: ICON plc is a global CRO with significant site-management operations following its PRA Health Sciences acquisition. It is a broad incumbent peer competing for Phase I-IV sponsor contracts and influencing site qualification standards.

Market position

Customer concentration

• Xx.com/icresearchtn

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about International Clinical Research